| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 1.246 | 2.555 | 2.064 | 567 | 4.236 | 9.123 | 15.991 |
| Total Income - EUR | - | - | - | 1.246 | 2.555 | 2.064 | 567 | 4.236 | 9.123 | 16.050 |
| Total Expenses - EUR | - | - | - | 1.276 | 1.865 | 1.455 | 1.222 | 2.597 | 6.262 | 7.527 |
| Gross Profit/Loss - EUR | - | - | - | -31 | 690 | 609 | -655 | 1.639 | 2.861 | 8.523 |
| Net Profit/Loss - EUR | - | - | - | -68 | 614 | 552 | -666 | 1.515 | 2.106 | 6.694 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Dr Luciana Oprea S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 822 | 296 | 0 | 752 | 416 |
| Current Assets | - | - | - | 257 | 649 | 373 | 143 | 2.025 | 4.704 | 6.659 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 0 | 0 | 1 | 0 | 76 | 0 |
| Cash | - | - | - | 257 | 649 | 373 | 141 | 2.025 | 4.629 | 6.659 |
| Shareholders Funds | - | - | - | -25 | 589 | 1.130 | 439 | 1.955 | 4.055 | 6.793 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 282 | 60 | 65 | 0 | 70 | 1.401 | 281 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dr Luciana Oprea S.r.l.